CogenDx

CogenDx is a molecular diagnostics company that specializes in advanced pathogen detection and identification services. As a division of the Genetics Institute of America, the company utilizes high-complexity molecular testing to provide rapid and accurate results for various infectious diseases. Their service portfolio includes comprehensive panels for wound care, urinary tract infections, respiratory infections, and nail health. By leveraging Polymerase Chain Reaction (PCR) technology, CogenDx aims to improve clinical decision-making and patient outcomes through precise microbial identification and antibiotic resistance profiling. The company serves healthcare providers by delivering actionable data that facilitates targeted treatment strategies.